This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Prognostic value of the NLR combined with CIP2A in the serum of patients with colorectal cancer
BMC Surgery Open Access 18 June 2021
-
Effect of CIP2A and its mechanism of action in the malignant biological behavior of colorectal cancer
Cell Communication and Signaling Open Access 22 April 2020
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Liu H, Qiu H, Song Y, Liu Y, Wang H, Lu M et al. Cip2a promotes cell cycle progression in triple-negative breast cancer cells by regulating the expression and nuclear export of p27Kip1. Oncogene 2016,; e-pub ahead of print 3 October 2016 doi:10.1038/onc.2016.355.
Come C, Laine A, Chanrion M, Edgren H, Mattila E, Liu X et al. CIP2A is associated with human breast cancer aggressivity. Clin Cancer Res 2009; 15: 5092–5100.
Laine A, Sihto H, Come C, Rosenfeldt MT, Zwolinska A, Niemela M et al. Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1. Cancer Discov 2013; 3: 182–197.
Rincón R, Cristóbal I, Zazo S, Arpí O, Menéndez S, Manso R et al. PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects. Oncotarget 2015; 6: 4299–4314.
Acknowledgements
This work was supported by PT13/0010/0012, PI13/02609 and PI15/00934 grants from ‘Instituto de Salud Carlos III FEDER’. BT is supported by ‘Fundación Conchita Rábago de Jiménez Díaz’.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Cristóbal, I., Zazo, S., Torrejón, B. et al. CIP2A confirms its prognostic value in triple-negative breast cancer. Oncogene 36, 3357–3358 (2017). https://doi.org/10.1038/onc.2016.474
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2016.474
This article is cited by
-
Prognostic value of the NLR combined with CIP2A in the serum of patients with colorectal cancer
BMC Surgery (2021)
-
Effect of CIP2A and its mechanism of action in the malignant biological behavior of colorectal cancer
Cell Communication and Signaling (2020)